METTL3 and esophageal squamous cell carcinoma: In vitro cellular experiments, and gain- and loss-of function assays, demonstrated that METTL3 could promote ESCC migration and invasion, indicating that METTL3 might act as an oncogene in ESCC tumorigenesis.